MAPK1 and cancer: Pathways of neurodegeneration-multiple diseases There are ten anti-cancer/tumor-associated targets, namely MAPK10, GSK3B, APP, CASP7, CASP8, CSNK2A1, HSPA5, CASP3, MAPK1, and PRKCA.